Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001592526 | SCV001827131 | uncertain significance | not provided | 2022-05-16 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001592526 | SCV002448385 | likely benign | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Clinical Genomics Laboratory, |
RCV005051912 | SCV005685376 | uncertain significance | Van Maldergem syndrome 2 | 2024-09-13 | criteria provided, single submitter | clinical testing | A FAT4 c.8537G>A (p.Arg2846Gln) variant was identified at a near heterozygous allelic fraction of 48.5%, a frequency which may be consistent with germline origin. This variant, to our knowledge, has not been reported in the medical literature. This variant is observed on 87/1,613,416 alleles in the general population (gnomAD v.4.1.0). The FAT4 c.8537G>A (p.Arg2846Gln) variant has been reported in the ClinVar database as a variant of uncertain significance by one submitter and a likely benign variant by one submitter (ClinVar variation ID: 1220268). Computational predictors suggest that the variant does not impact FAT4 function. Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. |